Expert: Richard Anderson, University of Edinburgh, Edinburgh, UK
Questions:
1- Frequency of fertility loss (in men and women) after most often chemotherapy regimens used in young patients with cancer (ABVD, BEACOPPesc, others, targeted therapies).
2- Effectiveness of ovarian function suppression by GnRH analogues in women as a means of fertility preservation.
3- Effectiveness of various fertility preservation techniques (sperm preservation, oocyte cryopreservation and others) in conjunction with cancer treatment.
4- Timing and peculiarities of pregnancy after cancer treatment (mostly Hodgkin and non-Hodgkin lymphoma, breast cancer).
5- Peculiarities of ovulation stimulation in breast cancer patients (HR+ and HR-).
